Rock Ventures Iv L.P. Third also recently made the following trade(s):Get Tango Therapeutics alerts:On Tuesday, September 16th, Rock Ventures Iv L.P. Third sold 363,541 shares of Tango Therapeutics stock. On Monday, September 8th, Rock Ventures Iv L.P. Third sold 86,459 shares of Tango Therapeutics stock. The company has a fifty day moving average price of $6.90 and a two-hundred day moving average price of $4.28. Tango Therapeutics Company Profile(Get Free Report)Tango Therapeutics, Inc, a biotechnology company, discovers and develops drugs for the treatment of cancer. Further ReadingReceive News & Ratings for Tango Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tango Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.